Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease.
den Exter PL, Woller SC, Robert-Ebadi H, Masias C, Morange PE, Castelli D, Hansen JB, Geersing GJ, Siegal DM, de Wit K, Klok FA.
den Exter PL, et al. Among authors: siegal dm.
J Thromb Haemost. 2022 Aug;20(8):1910-1919. doi: 10.1111/jth.15776. Epub 2022 Jun 23.
J Thromb Haemost. 2022.
PMID: 35735219
Free PMC article.
Identification of patients at high risk of bleeding, and mitigating this risk, is an essential component of the immediate and long-term therapeutic management of VTE. The bleeding risk can be estimated by either implicit judgment, weighing individual predictors (clinical v …
Identification of patients at high risk of bleeding, and mitigating this risk, is an essential component of the immediate and long-term …